Hepatocellular liver injury in hospitalized patients affected by COVID-19: Presence of different risk factors at different time points

{ 'indexed': {'date-parts': [[2023, 1, 12]], 'date-time': '2023-01-12T07:52:31Z', 'timestamp': 1673509951295}, 'reference-count': 32, 'publisher': 'Elsevier BV', 'issue': '5', 'license': [ { 'start': { 'date-parts': [[2022, 5, 1]], 'date-time': '2022-05-01T00:00:00Z', 'timestamp': 1651363200000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://www.elsevier.com/tdm/userlicense/1.0/'}], 'content-domain': { 'domain': [ 'clinicalkey.fr', 'clinicalkey.jp', 'dldjournalonline.com', 'clinicalkey.es', 'clinicalkey.com.au', 'clinicalkey.com', 'elsevier.com', 'sciencedirect.com'], 'crossmark-restriction': True}, 'published-print': {'date-parts': [[2022, 5]]}, 'DOI': '10.1016/j.dld.2021.12.014', 'type': 'journal-article', 'created': { 'date-parts': [[2021, 12, 27]], 'date-time': '2021-12-27T03:32:49Z', 'timestamp': 1640575969000}, 'page': '565-571', 'update-policy': 'http://dx.doi.org/10.1016/elsevier_cm_policy', 'source': 'Crossref', 'is-referenced-by-count': 3, 'title': 'Hepatocellular liver injury in hospitalized patients affected by COVID-19: Presence of different ' 'risk factors at different time points', 'prefix': '10.1016', 'volume': '54', 'author': [ { 'ORCID': 'http://orcid.org/0000-0002-0581-4850', 'authenticated-orcid': False, 'given': 'M.', 'family': 'Leo', 'sequence': 'first', 'affiliation': []}, {'given': 'A.', 'family': 'Galante', 'sequence': 'additional', 'affiliation': []}, {'given': 'A.', 'family': 'Pagnamenta', 'sequence': 'additional', 'affiliation': []}, {'given': 'L.', 'family': 'Ruinelli', 'sequence': 'additional', 'affiliation': []}, {'given': 'F.R.', 'family': 'Ponziani', 'sequence': 'additional', 'affiliation': []}, {'given': 'A.', 'family': 'Gasbarrini', 'sequence': 'additional', 'affiliation': []}, {'given': 'A.', 'family': 'De Gottardi', 'sequence': 'additional', 'affiliation': []}], 'member': '78', 'reference': [ { 'key': '10.1016/j.dld.2021.12.014_bib0001', 'doi-asserted-by': 'crossref', 'first-page': '1708', 'DOI': '10.1056/NEJMoa2002032', 'article-title': 'Clinical characteristics of coronavirus disease 2019 in China', 'volume': '382', 'author': 'Guan', 'year': '2020', 'journal-title': 'N Engl J Med'}, { 'key': '10.1016/j.dld.2021.12.014_bib0002', 'doi-asserted-by': 'crossref', 'first-page': '1239', 'DOI': '10.1001/jama.2020.2648', 'article-title': 'Characteristics of and important lessons from the coronavirus disease ' '2019 (COVID-19) outbreak in China: summary of a report of 72\xa0314 ' 'cases from the Chinese Center for Disease Control and Prevention', 'volume': '323', 'author': 'Wu', 'year': '2020', 'journal-title': 'JAMA'}, { 'key': '10.1016/j.dld.2021.12.014_bib0003', 'doi-asserted-by': 'crossref', 'first-page': '667', 'DOI': '10.1016/S2468-1253(20)30126-6', 'article-title': 'Manifestations and prognosis of gastrointestinal and liver involvement ' 'in patients with COVID-19: a systematic review and meta-analysis', 'volume': '5', 'author': 'Mao', 'year': '2020', 'journal-title': 'Lancet Gastroenterol Hepatol'}, { 'key': '10.1016/j.dld.2021.12.014_bib0004', 'doi-asserted-by': 'crossref', 'first-page': '566', 'DOI': '10.1016/j.jhep.2020.04.006', 'article-title': 'COVID-19: abnormal liver function tests', 'volume': '73', 'author': 'Cai', 'year': '2020', 'journal-title': 'J Hepatol'}, { 'key': '10.1016/j.dld.2021.12.014_bib0005', 'doi-asserted-by': 'crossref', 'first-page': '497', 'DOI': '10.1016/S0140-6736(20)30183-5', 'article-title': 'Clinical features of patients infected with 2019 novel coronavirus in ' 'Wuhan', 'volume': '395', 'author': 'Huang', 'year': '2020', 'journal-title': 'China. Lancet.'}, { 'key': '10.1016/j.dld.2021.12.014_bib0006', 'doi-asserted-by': 'crossref', 'first-page': '890', 'DOI': '10.1002/hep.31326', 'article-title': 'Liver biochemistries in hospitalized patients with COVID-19', 'volume': '73', 'author': 'Bloom', 'year': '2020', 'journal-title': 'Hepatology'}, { 'key': '10.1016/j.dld.2021.12.014_bib0007', 'doi-asserted-by': 'crossref', 'first-page': '807', 'DOI': '10.1002/hep.31404', 'article-title': 'Acute liver injury in COVID-19: prevalence and association with ' 'clinical outcomes in a large U.S. cohort', 'volume': '72', 'author': 'Phipps', 'year': '2020', 'journal-title': 'Hepatology'}, { 'key': '10.1016/j.dld.2021.12.014_bib0008', 'doi-asserted-by': 'crossref', 'first-page': '507', 'DOI': '10.1016/S0140-6736(20)30211-7', 'article-title': 'Epidemiological and clinical characteristics of 99 cases of 2019 novel ' 'coronavirus pneumonia in Wuhan, China: a descriptive study', 'volume': '395', 'author': 'Chen', 'year': '2020', 'journal-title': 'Lancet'}, { 'key': '10.1016/j.dld.2021.12.014_bib0009', 'first-page': '13072', 'article-title': 'Prevalence of liver injury and correlation with clinical outcomes in ' 'patients with COVID-19: systematic review with meta-analysis', 'volume': '24', 'author': 'Del Zompo', 'year': '2020', 'journal-title': 'Eur Rev Med Pharmacol Sci'}, { 'key': '10.1016/j.dld.2021.12.014_bib0010', 'doi-asserted-by': 'crossref', 'first-page': '1365', 'DOI': '10.1136/gutjnl-2020-321350', 'article-title': 'Severe liver failure during SARS-CoV-2 infection', 'volume': '69', 'author': 'Weber', 'year': '2020', 'journal-title': 'Gut'}, { 'key': '10.1016/j.dld.2021.12.014_bib0011', 'doi-asserted-by': 'crossref', 'first-page': '428', 'DOI': '10.1016/S2468-1253(20)30057-1', 'article-title': 'Liver injury in COVID-19: management and challenges', 'volume': '5', 'author': 'Zhang', 'year': '2020', 'journal-title': 'Lancet Gastroenterol Hepatol'}, { 'key': '10.1016/j.dld.2021.12.014_bib0012', 'doi-asserted-by': 'crossref', 'first-page': '175', 'DOI': '10.1002/cld.967', 'article-title': 'Interrelationship between coronavirus infection and liver disease', 'volume': '15', 'author': 'Schaefer', 'year': '2020', 'journal-title': 'Clin Liver Dis (Hoboken)'}, { 'key': '10.1016/j.dld.2021.12.014_bib0013', 'doi-asserted-by': 'crossref', 'first-page': '1087', 'DOI': '10.1053/j.gastro.2016.09.048', 'article-title': 'Innate immune cell trafficking and function during sterile inflammation ' 'of the liver', 'volume': '151', 'author': 'McDonald', 'year': '2016', 'journal-title': 'Gastroenterology'}, { 'key': '10.1016/j.dld.2021.12.014_bib0014', 'doi-asserted-by': 'crossref', 'first-page': '998', 'DOI': '10.1111/liv.14435', 'article-title': 'Liver injury during highly pathogenic human coronavirus infections', 'volume': '40', 'author': 'Xu', 'year': '2020', 'journal-title': 'Liver Int'}, { 'key': '10.1016/j.dld.2021.12.014_bib0015', 'doi-asserted-by': 'crossref', 'first-page': '504', 'DOI': '10.1164/ajrccm.152.2.7633699', 'article-title': 'Effects of PEEP on liver arterial and venous blood flows', 'volume': '152', 'author': 'Brienza', 'year': '1995', 'journal-title': 'Am J Respir Crit Care Med'}, { 'key': '10.1016/j.dld.2021.12.014_bib0016', 'article-title': 'Specific ACE2 expression in cholangiocytes may cause liver damage after ' '2019-nCoV infection', 'author': 'Chai', 'year': '2020', 'journal-title': 'bioRxiv'}, { 'key': '10.1016/j.dld.2021.12.014_bib0017', 'doi-asserted-by': 'crossref', 'first-page': '271', 'DOI': '10.1016/j.cell.2020.02.052', 'article-title': 'SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a ' 'clinically proven protease inhibitor', 'volume': '181', 'author': 'Hoffmann', 'year': '2020', 'journal-title': 'Cell.'}, { 'key': '10.1016/j.dld.2021.12.014_bib0018', 'first-page': '21', 'article-title': 'General anatomy report of novel coronavirus pneumonia patients', 'volume': '36', 'author': 'Liu', 'year': '2020', 'journal-title': 'Journal of Forensic Medicine'}, { 'key': '10.1016/j.dld.2021.12.014_bib0019', 'doi-asserted-by': 'crossref', 'first-page': '807', 'DOI': '10.1016/j.jhep.2020.05.002', 'article-title': 'SARS-CoV-2 infection of the liver directly contributes to hepatic ' 'impairment in patients with COVID-19', 'volume': '73', 'author': 'Wang', 'year': '2020', 'journal-title': 'J Hepatol'}, { 'key': '10.1016/j.dld.2021.12.014_bib0020', 'doi-asserted-by': 'crossref', 'first-page': '991', 'DOI': '10.1016/j.jhep.2020.05.025', 'article-title': 'SARS-CoV-2 related liver impairment - perception may not be the reality', 'volume': '73', 'author': 'Philips', 'year': '2020', 'journal-title': 'J Hepatol'}, { 'key': '10.1016/j.dld.2021.12.014_bib0021', 'doi-asserted-by': 'crossref', 'first-page': '1561', 'DOI': '10.1016/j.cgh.2020.04.002', 'article-title': 'Clinical features of COVID-19-related liver functional abnormality', 'volume': '18', 'author': 'Fan', 'year': '2020', 'journal-title': 'Clin Gastroenterol Hepatol'}, { 'key': '10.1016/j.dld.2021.12.014_bib0022', 'first-page': '1060', 'article-title': 'Liver involvement is not associated with mortality: results from a ' 'large cohort of SARS-CoV-2-positive patients', 'volume': '52', 'author': 'Ponziani', 'year': '2020', 'journal-title': 'Aliment Pharmacol Ther'}, { 'key': '10.1016/j.dld.2021.12.014_bib0023', 'doi-asserted-by': 'crossref', 'first-page': '1295', 'DOI': '10.1016/j.jhep.2020.12.012', 'article-title': 'Association of liver abnormalities with in-hospital mortality in ' 'patients with COVID-19', 'volume': '74', 'author': 'Ding', 'year': '2021', 'journal-title': 'J Hepatol'}, { 'key': '10.1016/j.dld.2021.12.014_bib0024', 'unstructured': 'National Institutes of Health, National Cancer Institute, U.S. ' 'Department of Health and Human Services. Common Terminology Criteria for ' 'Adverse Events (CTCAE) version 5.0. ' 'https://ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/CTCAE_v5_Quick_Reference_8.5x11.pdf. ' 'Published November 27, 2017.'}, { 'key': '10.1016/j.dld.2021.12.014_bib0025', 'doi-asserted-by': 'crossref', 'first-page': '459', 'DOI': '10.1038/s41586-020-2286-9', 'article-title': 'A SARS-CoV-2 protein interaction map reveals targets for drug ' 'repurposing', 'volume': '583', 'author': 'Gordon', 'year': '2020', 'journal-title': 'Nature'}, { 'key': '10.1016/j.dld.2021.12.014_bib0026', 'doi-asserted-by': 'crossref', 'first-page': '389', 'DOI': '10.1002/hep.31301', 'article-title': 'Longitudinal association between markers of liver injury and mortality ' 'in COVID-19 in China', 'volume': '72', 'author': 'Lei', 'year': '2020', 'journal-title': 'Hepatology'}, { 'key': '10.1016/j.dld.2021.12.014_bib0027', 'doi-asserted-by': 'crossref', 'first-page': '451', 'DOI': '10.1016/j.jhep.2020.03.044', 'article-title': 'Non-alcoholic fatty liver diseases in patients with COVID-19: a ' 'retrospective study', 'volume': '73', 'author': 'Ji', 'year': '2020', 'journal-title': 'J Hepatol'}, { 'key': '10.1016/j.dld.2021.12.014_bib0028', 'doi-asserted-by': 'crossref', 'first-page': '1102', 'DOI': '10.1002/jgh3.12395', 'article-title': 'Hepatic steatosis as an independent risk factor for severe disease in ' 'patients with COVID-19: a computed tomography study', 'volume': '4', 'author': 'Palomar-Lever', 'year': '2020', 'journal-title': 'JGH Open'}, { 'key': '10.1016/j.dld.2021.12.014_bib0029', 'doi-asserted-by': 'crossref', 'first-page': '44', 'DOI': '10.1002/hep.20734', 'article-title': 'Prevalence of and risk factors for nonalcoholic fatty liver disease: ' 'the Dionysos nutrition and liver study', 'volume': '42', 'author': 'Bedogni', 'year': '2005', 'journal-title': 'Hepatology'}, { 'key': '10.1016/j.dld.2021.12.014_bib0030', 'first-page': '212', 'article-title': 'Role of nonalcoholic fatty liver disease as risk factor for ' 'drug-induced hepatotoxicity', 'volume': '3', 'author': 'Massart', 'year': '2017', 'journal-title': 'J Clin Transl Res'}, { 'key': '10.1016/j.dld.2021.12.014_bib0031', 'doi-asserted-by': 'crossref', 'first-page': '733', 'DOI': '10.1016/j.chest.2017.08.018', 'article-title': 'Cholestatic Alterations in the Critically Ill: some New Light on an Old ' 'Problem', 'volume': '153', 'author': 'Jenniskens', 'year': '2018', 'journal-title': 'Chest'}, { 'key': '10.1016/j.dld.2021.12.014_bib0032', 'doi-asserted-by': 'crossref', 'first-page': '1864', 'DOI': '10.1002/hep.31480', 'article-title': 'Abnormal liver function tests in patients with COVID-19: relevance and ' 'potential pathogenesis', 'volume': '72', 'author': 'Bertolini', 'year': '2020', 'journal-title': 'Hepatology'}], 'container-title': 'Digestive and Liver Disease', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://api.elsevier.com/content/article/PII:S1590865821009233?httpAccept=text/xml', 'content-type': 'text/xml', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://api.elsevier.com/content/article/PII:S1590865821009233?httpAccept=text/plain', 'content-type': 'text/plain', 'content-version': 'vor', 'intended-application': 'text-mining'}], 'deposited': { 'date-parts': [[2022, 4, 25]], 'date-time': '2022-04-25T11:25:29Z', 'timestamp': 1650885929000}, 'score': 1, 'resource': {'primary': {'URL': 'https://linkinghub.elsevier.com/retrieve/pii/S1590865821009233'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2022, 5]]}, 'references-count': 32, 'journal-issue': {'issue': '5', 'published-print': {'date-parts': [[2022, 5]]}}, 'alternative-id': ['S1590865821009233'], 'URL': 'http://dx.doi.org/10.1016/j.dld.2021.12.014', 'relation': {}, 'ISSN': ['1590-8658'], 'subject': ['Gastroenterology', 'Hepatology'], 'container-title-short': 'Digestive and Liver Disease', 'published': {'date-parts': [[2022, 5]]}, 'assertion': [ {'value': 'Elsevier', 'name': 'publisher', 'label': 'This article is maintained by'}, { 'value': 'Hepatocellular liver injury in hospitalized patients affected by COVID-19: ' 'Presence of different risk factors at different time points', 'name': 'articletitle', 'label': 'Article Title'}, {'value': 'Digestive and Liver Disease', 'name': 'journaltitle', 'label': 'Journal Title'}, { 'value': 'https://doi.org/10.1016/j.dld.2021.12.014', 'name': 'articlelink', 'label': 'CrossRef DOI link to publisher maintained version'}, {'value': 'article', 'name': 'content_type', 'label': 'Content Type'}, { 'value': '© 2021 Published by Elsevier Ltd on behalf of Editrice Gastroenterologica ' 'Italiana S.r.l.', 'name': 'copyright', 'label': 'Copyright'}]}